Ketorolac (systemic) vs Thrombolytic Agents

Interacting Drugs
Ketorolac (systemic)
vs
Thrombolytic Agents
Security Level
Minor, Monitor Therapy
Mechanism
Thrombolytic Agents: Antiplatelet Agents may enhance the anticoagulant effect of Thrombolytic Agents.
Management
Monitor therapy

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Ketorolac (systemic) vs Thrombolytic Agents